STIFEL FINANCIAL CORP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 165 filers reported holding NEKTAR THERAPEUTICS in Q4 2014. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2019$369,000
+8.2%
10,350
+1.7%
0.00%0.0%
Q1 2019$341,000
+34.8%
10,173
+31.8%
0.00%0.0%
Q4 2018$253,000
-69.6%
7,718
-43.5%
0.00%
-50.0%
Q3 2018$833,000
+23.6%
13,664
-1.0%
0.00%0.0%
Q2 2018$674,000
-60.7%
13,798
-14.5%
0.00%
-60.0%
Q1 2018$1,715,000
+11.8%
16,137
-37.1%
0.01%0.0%
Q4 2017$1,534,000
+139.7%
25,670
-3.7%
0.01%
+150.0%
Q3 2017$640,000
+22.4%
26,656
-0.2%
0.00%0.0%
Q2 2017$523,000
-23.5%
26,702
-8.3%
0.00%
-33.3%
Q1 2017$684,000
+114.4%
29,111
+12.1%
0.00%
+200.0%
Q4 2016$319,000
+58.7%
25,973
+117.3%
0.00%0.0%
Q4 2015$201,000
-51.4%
11,951
-63.8%
0.00%0.0%
Q2 2015$414,000
+113.4%
33,000
+86.4%
0.00%0.0%
Q1 2015$194,000
-29.2%
17,7000.0%0.00%
-50.0%
Q4 2014$274,000
+85.1%
17,700
+43.9%
0.00%
+100.0%
Q3 2014$148,000
-7.5%
12,300
-1.0%
0.00%0.0%
Q2 2014$160,000
+6.7%
12,420
+0.8%
0.00%0.0%
Q1 2014$150,00012,3200.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2014
NameSharesValueWeighting ↓
Camber Capital Management LP 2,000,000$67,200,0003.35%
First Light Asset Management, LLC 763,403$25,650,0003.33%
BRIDGER MANAGEMENT, LLC 1,238,489$41,613,0003.29%
Rhenman & Partners Asset Management AB 734,445$24,677,0002.89%
BB BIOTECH AG 2,020,676$67,895,0001.71%
Gs Investments, Inc. 54,200$1,821,120,0001.43%
Artal Group S.A. 900,000$30,240,0001.24%
Cormorant Asset Management, LP 500,000$16,800,0001.14%
TOBAM 640,547$21,522,0001.09%
Bellevue Group AG 430,026$14,449,0000.80%
View complete list of NEKTAR THERAPEUTICS shareholders